PLAINSBORO, N.J.-- May 7, 2013 -- OncLive® is pleased to announce that the Herbert Irving Comprehensive Cancer Center has joined its Strategic Alliance Partnership program.
This program enables the Herbert Irving Comprehensive Cancer Center to promote its institution and faculty as leaders in oncology to a national audience of oncology professionals through OncologyLive, Oncology & Biotech News, Oncology Nursing News, and www.OncLive.com.
OncLive offers a suite of leading oncology publications and websites, and through its reach provides oncology professionals with the latest data and cutting-edge research. Through the partnership, both parties will benefit from shared knowledge and increased visibility in the oncology community.
The Herbert Irving Comprehensive Cancer Center is Columbia University’s organizational structure for the conduct of cancer research and patient care. It is one of only 41 National Cancer Institute-designated comprehensive cancer centers in the country.
“We are thrilled to have the Herbert Irving Comprehensive Cancer Center on board as a strategic partner,” said Jack Lepping, president of the oncology division of Intellisphere, the publisher of OncLive. “The Herbert Irving Comprehensive Cancer Center is a national leader in research, and we can’t wait to share more of its faculty’s important work with our readers.”
This year, 15 cancer centers and nursing schools have joined OncLive’s Strategic Alliance Partnership program.
To learn more about OncLive®, visit www.OncLive.com.
OncLive.com is the official website for Intellisphere’s Oncology Specialty Group, which publishes Oncology & Biotech News, OncologyLive, Oncology Nursing News, and Contemporary Oncology. The mission of OncLive® and its family of publications is to provide oncology professionals with the resources and information they need in order to provide the best care for their patients. The Oncology Specialty Group is a division of Intellisphere, LLC, a leading provider of health care publishing, research and education. To learn more, please visit www.OncLive.com.